A census of human cancer genes (original) (raw)

• Reddy, E. P., Reynolds, R. K., Santos, E. & Barbacid, M. A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300, 149–152 (1982).
  Article CAS PubMed Google Scholar
• Tabin, C. J. et al. Mechanism of activation of a human oncogene. Nature 300, 143–149 (1982). References 1 and 2 are seminal papers that defined the existence of oncogene sequences in cancer-cell genomes and that first identified a mutation involved in human cancer.
  Article CAS PubMed Google Scholar
• Parsons, R. et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75, 1227–1236 (1993).
  Article CAS PubMed Google Scholar
• Fishel, R. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75, 1027–1038 (1993).
  Article CAS PubMed Google Scholar
• Leach, F. S. et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75, 1215–1225 (1993).
  Article CAS PubMed Google Scholar
• Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686–692 (1995).
  Article CAS PubMed Google Scholar
• Kane, M. F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808–811 (1997).
  CAS PubMed Google Scholar
• Baylin, S. & Bestor, T. H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1, 299–305 (2002).
  Article CAS PubMed Google Scholar
• Duval, A. & Hamelin, R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 62, 2447–2454 (2002).
  CAS PubMed Google Scholar
• Duval, A. et al. Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum. Mol. Genet. 10, 513–518 (2001).
  Article CAS PubMed Google Scholar
• Grady, W. M. et al. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res. 59, 320–324 (1999).
  CAS PubMed Google Scholar
• Ohta, M. et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587–597 (1996).
  Article CAS PubMed Google Scholar
• Bednarek, A. K. et al. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60, 2140–2145 (2000).
  CAS PubMed Google Scholar
• Sutherland, G. R., Baker, E. & Richards, R. I. Fragile sites still breaking. Trends Genet. 14, 501–506 (1998).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).
  Article CAS PubMed Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1946 (1997).
  Article CAS PubMed Google Scholar
• Laken, S. J. et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet. 17, 79–83 (1997).
  Article CAS PubMed Google Scholar
• Meijers-Heijboer, H. et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genet. 31, 55–59 (2002).
  Article CAS PubMed Google Scholar
• Shih, C., Shilo, B. Z., Goldfarb, M. P., Dannenberg, A. & Weinberg, R. A. Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl Acad. Sci. USA 76, 5714–5718 (1979).
  Article CAS PubMed PubMed Central Google Scholar
• Krontiris, T. G. & Cooper, G. M. Transforming activity of human tumor DNAs. Proc. Natl Acad. Sci. USA 78, 1181–1184 (1981).
  Article CAS PubMed PubMed Central Google Scholar
• Baker, S. J. et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50, 7717–7722 (1990).
  CAS PubMed Google Scholar
• Hwang, S. -J., Lozano, G., Amos, C. I. & Strong, L. C. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am. J. Hum. Genet. 72, 975–983 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hemminki, A. et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome. Nature 391, 184–187 (1998).
  Article CAS PubMed Google Scholar
• Sanchez-Cespedes, M. et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659–3662 (2002).
  CAS PubMed Google Scholar
• Futreal, P. A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
  Article CAS PubMed Google Scholar
• Lancaster, J. M. et al. BRCA2 mutations in primary breast and ovarian cancers. Nature Genet. 13, 238–240 (1996).
  Article CAS PubMed Google Scholar
• Nikiforov, Y. E. RET/PTC rearrangement in thyroid tumors. Endocr. Pathol. 13, 3–16 (2002).
  Article CAS PubMed Google Scholar
• Kroll, T. G. et al. _PAX_8–_PPAR_γ1 fusion in oncogene human thyroid carcinoma. Science 289, 1357–1360 (2000).
  Article CAS PubMed Google Scholar
• Sidhar, S. K. et al. The t(X;1)(p11. 2;q21. 2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum. Molec. Genet. 5, 1333–1338 (1996).
  Article CAS PubMed Google Scholar
• Tognon, C. et al. Expression of the ETV6_–_NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2, 367–376 (2002).
  Article CAS PubMed Google Scholar
• Ayton, P. M. & Cleary, M. L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20, 5695–5707 (2001).
  Article CAS PubMed Google Scholar
• Eng, C. & Mulligan, L. M. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum. Mutat. 9, 97–109 (1997).
  Article CAS PubMed Google Scholar
• Wong, A. J. et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl Acad. Sci. USA 89, 2965–2969 (1992).
  Article CAS PubMed PubMed Central Google Scholar
• Zhuang, Z. et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nature Genet. 20, 66–69 (1998).
  Article CAS PubMed Google Scholar
• Bongarzone, I. et al. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Molec. Cell. Biol. 13, 358–366 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Kirschner, L. S. et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nature Genet. 26, 89–92 (2000).
  Article CAS PubMed Google Scholar
• Bateman, A. et al. The Pfam protein families database. Nucleic Acids Res. 30, 276–280 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749–1753 (1995).
  Article CAS PubMed Google Scholar
• Howe, J. R. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nature Genet. 28, 184–187 (2001).
  Article CAS PubMed Google Scholar
• Gilliland, D. G. & Griffin, J. D. The roles of FLT3 in hematopoiesis and leukemia. Blood 100, 1532–1542 (2002).
  Article CAS PubMed Google Scholar
• Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577–580 (1998).
  Article CAS PubMed Google Scholar
• Heinrich, M. C. et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299, 708–710 (2003).
  Article CAS PubMed Google Scholar